$2.95
Price
$191M
Market Cap
—
P/E Ratio
-1.8
Forward P/E
$-2.08
EPS (TTM)
—
Dividend Yield
$281M
Cash
$40M
Total Debt
65M
Shares Out
$1.01
$3.95
52-Week Range
Institutional Ownership of ZENTALIS PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ZENTALIS PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q3 | |||||
| SELL | EXIT | — | — | $28.07 | |
| 2022-Q2 | |||||
| SELL | -4.3% | 2.0M | $57M | $24.75 | |
| 2021-Q3 | |||||
| SELL | -11.7% | 2.1M | $141M | $53.41 | |
| 2021-Q1 | |||||
| SELL | -20.3% | 2.4M | $104M | $42.19 | |
| 2020-Q4 | |||||
| SELL | -32.2% | 3.0M | $156M | $41.80 | |
| 2020-Q2 | |||||
| BUY | NEW | 4.4M | $213M | $38.52 | |
Insider Trading for ZENTALIS PHARMACEUTICALS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.